Position in ALKS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$291,541
-$227,339 QoQ
Shares Held
8,245
-52.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 98.96907216494846.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0309278350515463.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Bancorp USA Inc. holds $247,646,198 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,686,470 | $199,357,617 | |
| 2 | HLN |
Haleon plc
|
3,953,513 | $39,574,665 | |
| 3 | VTRS |
Viatris Inc
|
348,892 | $4,713,529 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,749 | $1,630,101 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
4,849 | $638,806 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
21,972 | $456,137 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
4,937 | $374,470 | |
| 8 | ALKS |
Alkermes plc.
This page
|
8,245 | $291,541 |
All Filings in ALKS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $291,541 | 8,245 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $518,880 | 17,296 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||